Diagnostics News and Research

RSS

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

Ethicon Endo-Surgery receives FDA 510(k) clearance for Advanced Energy Generator

In an effort to help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) today announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advanced bipolar technologies and designed for easy set set-up and use in the operating room.

15 Jun 2011

QIAGEN to acquire Ipsogen

QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.

From QIAGEN Manchester Limited 15 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

GSK, Arecor enter license agreement to develop advanced formulations of vaccines

Arecor and GSK have entered into a license agreement to develop advanced formulations of vaccines combining Arecor's unique formulation technologies with GSK's proprietary vaccines.

15 Jun 2011

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.

15 Jun 2011

New ultrasound technique can measure blood pressure at many points in the body

Researchers at Eindhoven University of Technology, together with the Italian company Esaote, have developed a new technique to measure the blood pressure.

15 Jun 2011

DATATRAK adds Research Dynamics to Connect Partner Program

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the addition of Research Dynamics Consulting Group LTD to its Connect Partner Program.

14 Jun 2011

New molecular diagnostic test precisely identifies insect venom allergy

Bees, wasps and bumble bees pose a real health threat to individuals with venom allergy. One sting from these insects may cause potentially life-threatening anaphylactic reactions in people with these conditions.

14 Jun 2011

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.

14 Jun 2011

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

Response Biomedical Corporation announced that it has received a notification from the U.S. Food and Drug Administration (FDA) that its NTproBNP Assay did not meet the criteria to obtain a waiver under the Clinical Laboratory Improvement Amendments of 1988.

14 Jun 2011

FDA approves Cornell Dots for first-in-human clinical trial for treatment of cancer

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.

14 Jun 2011

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II diagnostic test, clearing the way for its sale in the United States.

14 Jun 2011

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced it has entered into an agreement with Life Technologies Corporation that will underpin a new program to provide next-generation sequencing analysis of solid tumors.

14 Jun 2011

Dual Body scan machine gets FDA nod

According to the U.S. Food and Drug Administration last Friday, Siemens AG's device that simultaneously performs two common diagnostic tests received clearance from them. The German engineering company's U.S.-based Siemens Medical Solutions, which is based in Pennsylvania, manufactures the device.

From Siemens Healthineers 13 Jun 2011

Larger trial study needed to decide fate of niacin

Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol).

10 Jun 2011

Centric Health first quarter revenue increases 67% to $23.0 million

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced financial results for the first quarter ended March 31, 2011.

10 Jun 2011

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

Luminex Corporation and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli infection.

From Luminex 10 Jun 2011

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients

The novel cardiac biomarker ST2 was highlighted in a presentation at last month's 2011 Heart Failure Congress of the European Society of Cardiology in Gothenburg, Sweden. As this study and others have demonstrated, a patient's ST2 level can help a physician better predict prognosis in ambulatory, chronic heart failure patients, which can allow physicians to more appropriately tailor care.

10 Jun 2011

Diagnostics News and Research

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Ethicon Endo-Surgery receives FDA 510(k) clearance for Advanced Energy Generator

QIAGEN to acquire Ipsogen

ESC publishes position paper to raise the profile of vulnerable plaques

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

GSK, Arecor enter license agreement to develop advanced formulations of vaccines

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

New ultrasound technique can measure blood pressure at many points in the body

DATATRAK adds Research Dynamics to Connect Partner Program

New molecular diagnostic test precisely identifies insect venom allergy

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

FDA approves Cornell Dots for first-in-human clinical trial for treatment of cancer

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Dual Body scan machine gets FDA nod

Larger trial study needed to decide fate of niacin

Centric Health first quarter revenue increases 67% to $23.0 million

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News